Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics. Founded by Eric Ostertag in 2015, Poseida Therapeutics is backed by investors that include Aisling Capital, Longitude Capital, Malin Corporation, Novartis, and Perceptive Advisors. Poseida Therapeutics is headquartered in San Diego.